Sensex, Nifty Register Longest Streak Of Weekly Decline In 11 Months – BloombergQuint

Shares of the drugmaker rose as much as 3.7% after it received an emergency use approval from DCGI for using Pegylated Interferon alpha-2b, ‘Virafin’ to treat moderate Covid-19 infection in adults.

A single dose subcutaneous regimen of the antiviral, Virafin, will help patients recover faster and avoid complications when administered early, Cadila said.

In a trial conducted in 20-25 centres across India, Virafin had shown lesser need for supplemental oxygen, indicating that it was able to control respiratory distress and failure.

Leave a Reply

Your email address will not be published. Required fields are marked *